Revisão sistemática | Paclitaxel com carboplatina 1 vez/semana vs. 1 vez a cada 3 semanas para tratamento de primeira linha em mulheres com câncer epitelial de ovário.

Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer – Cochrane Library

Resumo: Does weekly dosing of paclitaxel improve survival, compared with tri-weekly dosing of paclitaxel in the initial treatment of ovarian cancer? – Cochrane Library